CIAS
BEAT

Capital Investment Advisory Services’s BioTelemetry, Inc. BEAT Stock Holding History

Capital Investment Advisory Services’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$41K – 1419
2019
Q3 		$41K Hold
1,000
– – 0.01% 616
2019
Q2 		$45K Buy
+1,000
New +$52.6K 0.01% 580

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Capital Investment Advisory Services's BEAT Position: Q4 2019 in Review

Capital Investment Advisory Services sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 1,000 shares — an estimated $41K sold.

Capital Investment Advisory Services first reported a position in BEAT in Q2 2019 and held it in 2 quarters. The position peaked at $45K in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • Capital Investment Advisory Services reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • Capital Investment Advisory Services sold 1,000 BioTelemetry, Inc. shares in Q4 2019, an estimated $41K.
  • Capital Investment Advisory Services first reported a position in BioTelemetry, Inc. in Q2 2019 and held it in 2 quarters.
  • Capital Investment Advisory Services's BioTelemetry, Inc. position peaked at $45K in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on Capital Investment Advisory Services's 13F filing for Q4 2019, filed 4 Feb 2020.